Daniel Karp - Net Worth and Insider Trading
Daniel Karp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel Karp owns 1 companies in total, including Biogen Inc (BIIB) .
Click here to see the complete history of Daniel Karp’s form 4 insider trades.
Insider Ownership Summary of Daniel Karp
|Ticker||Comapny||Transaction Date||Type of Owner|
|BIIB||Biogen Inc||2018-06-11||EVP & Corporate Development|
Daniel Karp Trading Performance
Daniel Karp Ownership Network
Ownership Network List of Daniel Karp
Ownership Network Relation of Daniel Karp
Daniel Karp Owned Company Details
What does Biogen Inc do?
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021, followed by Leqembi in January 2023.
Who are the key executives at Biogen Inc?
Daniel Karp is the EVP & Corporate Development of Biogen Inc. Other key executives at Biogen Inc include Head of Development Priya Singhal , director & President and CEO Christopher Viehbacher , and Head of Pharm Ops and Tech Nicole Murphy .
Biogen Inc (BIIB) Insider Trades Summary
Over the past 18 months, Daniel Karp made no insider transaction in Biogen Inc (BIIB). Other recent insider transactions involving Biogen Inc (BIIB) include a net sale of 5,610 shares made by Ginger Gregory , and a net sale of 5,532 shares made by Susan H Alexander .
In summary, during the past 3 months, insiders sold 0 shares of Biogen Inc (BIIB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 11,142 shares of Biogen Inc (BIIB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 11,142 shares.
Biogen Inc (BIIB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biogen Inc Insider Transactions
Daniel Karp Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel Karp. You might contact Daniel Karp via mailing address: 225 Binney Street, Cambridge Ma 02142.